Welcome to our dedicated page for Neogen SEC filings (Ticker: NEOG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Neogen Corporation (NEOG) SEC filings page provides access to the company’s official regulatory disclosures filed with the U.S. Securities and Exchange Commission. These documents offer detailed insight into Neogen’s operations in food safety, animal safety, and related markets, as well as its governance, compensation practices, and financial condition.
Neogen uses current reports on Form 8-K to disclose material events such as the appointment of a new President and Chief Executive Officer, changes in the Chief Financial Officer role, director retirements and appointments, and the results of shareholder votes at its annual meeting. Filings describe executive compensation arrangements, including base salary, annual bonus targets, long-term equity incentives, and performance share unit programs tied to metrics like revenue growth, adjusted EBITDA margin expansion, and cash flow conversion.
Investors can also review 8-K filings that furnish earnings press releases, which summarize quarterly and annual results, segment performance for Food Safety and Animal Safety, and non-GAAP measures such as adjusted EBITDA. These filings complement the company’s financial statements by providing narrative context and reconciliations.
On Stock Titan, NEOG filings are updated as they are posted to EDGAR, and AI-powered summaries can help explain key elements of lengthy documents, including annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K. Users can quickly identify disclosures related to executive and director changes, incentive plans, shareholder meeting outcomes, and other governance matters.
This page is a resource for understanding how Neogen describes its strategy, risk factors, performance metrics, and capital structure in its own words through formal SEC filings, with tools to make complex regulatory content more accessible.
Ashima Gupta, a director of Neogen Corporation (NEOG), reported the vesting and settlement of 2,071 restricted stock units (RSUs) into 2,071 shares of common stock on
The filing is a routine Section 16 disclosure showing compensation‑related equity vesting rather than an open‑market buy or sell. The form was signed by an attorney‑in‑fact on
Neogen Corp director Ronald D. Green had 2,071 restricted stock units (RSUs) vest on
Jeffrey D. Capello, a director of Neogen Corporation (NEOG), had 2,071 restricted stock units vest and settle on
The settlement converted the RSUs into 2,071 shares of common stock at an indicated unit price of
Insider report: A director of Neogen Corporation (NEOG) had 2,071 restricted stock units vest and be settled for 2,071 shares of common stock on
William T. Boehm, a director of Neogen Corp (NEOG), had 2,071 restricted stock units vest and be settled into 2,071 shares of Common Stock on
Neogen Corp (NEOG) reported transactional and control updates for the quarter ended
Neogen Corporation filed a current report to note that it has released financial results for its fiscal 2026 first quarter, which ended on August 31, 2025. The company issued a press release on October 9, 2025 summarizing its operations and financial condition for that quarter, and attached this release as an exhibit to the report. The filing clarifies that the press release is being furnished, rather than filed, under securities laws, which affects how it is treated for certain legal and liability purposes.
Neogen Corporation reported that its Chief Financial Officer and Chief Operating Officer, David Naemura, has informed the company of his intention to resign to pursue other opportunities. The company stated that his decision is not related to any disagreement over operations, financial statements, accounting policies, or internal controls. He will continue in his current roles until a departure date expected between the filing of Neogen’s October Form 10-Q and the end of the calendar year, helping ensure continuity.
The board’s Compensation and Talent Management Committee determined it is in the company’s and shareholders’ best interests for Naemura to assist with onboarding a new Chief Financial Officer. Under a transition agreement, if he remains employed through December 31, 2025, he will be eligible, in addition to his base pay, to receive 50% of his annual target cash bonus under Neogen’s annual incentive plan. Neogen also issued a press release announcing his resignation.
The filing describes how certain executive Performance Stock Units (PSUs) will be settled after the end of the Performance Period. An independent committee will compare the Companys actual performance to the pre-established metrics and apply an rTSR multiplier to determine how many PSUs, if any, are earned. Any earned PSUs will be converted into shares of the Companys common stock and issued to the named executive officer as soon as practicable, and those shares will be fully vested upon issuance. Until settlement, the PSUs do not give the executives any ownership interest or shareholder rights.
Neogen Corp (NEOG) officer John Edward Adent reported the vesting and settlement of restricted stock units into common stock on August 18, 2025. The filing shows 35,736 RSUs vested and were settled for 35,736 shares at an effective price of $5.43 per share, increasing his direct holdings to 307,012 shares following the transaction. The Form 4 was signed by an attorney-in-fact on August 20, 2025.